We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+30.32%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$30M
AUM Growth
-$4.67M
Cap. Flow
-$6.12M
Cap. Flow %
-20.38%
Top 10 Hldgs %
58.16%
Holding
63
New
11
Increased
7
Reduced
13
Closed
22

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$1.07M
2
FEZ icon
State Street SPDR EURO STOXX 50 ETF
FEZ
+$983K
3
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$756K
4
FIT
Fitbit, Inc. Class A common stock
FIT
+$594K
5
KEM
KEMET Corporation
KEM
+$523K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.38M
2
VSM
Versum Materials, Inc.
VSM
+$1.93M
3
KDMN
Kadmon Holdings, Inc.
KDMN
+$1.58M
4
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$960K
5
MDSO
Medidata Solutions, Inc.
MDSO
+$897K

Sector Composition

Rank Sector Weight
1 Healthcare 65.46%
2 Miscellaneous 17.14%
3 Technology 5.05%
4 Communication Services 3.84%
5 Energy 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.87M 9.57%
8,700
+600
+7% +$180K
AGN
2
DELISTED
Allergan plc
AGN
$2.24M 7.45%
11,700
– –
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.09M 6.95%
460,788
-430,712
-48% -$1.58M
DERM
4
DELISTED
Dermira, Inc.
DERM
$2.06M 6.85%
135,559
-2,441
-2% -$21.1K
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.02M 6.74%
4,528
-2,706
-37% -$960K
WPX
6
CALL
DELISTED
WPX Energy, Inc.
WPX
$1.37M 4.58%
100,000
– –
ZSAN
7
DELISTED
Zosano Pharma Corporation
ZSAN
$1.31M 4.36%
24,614
+3,861
+19% +$238K
XTNT icon
8
Xtant Medical Holdings
XTNT
$53.9M
$1.21M 4.02%
752,915
-18,621
-2% -$38.2K
AFMD
9
DELISTED
Affimed
AFMD
$1.17M 3.89%
42,609
+14,542
+52% +$389K
EEM icon
10
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$1.12M 3.74%
+25,000
New +$1.07M
FEZ icon
11
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.52B
$1.02M 3.4%
+25,000
New +$983K
ACRS icon
12
Aclaris Therapeutics
ACRS
$885M
$833K 2.78%
441,000
+226,407
+106% +$375K
RARX
13
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$803K 2.68%
+17,100
New +$756K
GSAT icon
14
Globalstar
GSAT
$10.6B
$754K 2.51%
96,849
-9,087
-9% -$54.9K
FIT
15
DELISTED
Fitbit, Inc. Class A common stock
FIT
$665K 2.22%
+101,201
New +$594K
GLD icon
16
SPDR Gold Trust
GLD
$149B
$643K 2.14%
4,500
– –
VRAY
17
DELISTED
ViewRay, Inc.
VRAY
$629K 2.1%
148,951
-2,606
-2% -$8.42K
ADMA icon
18
ADMA Biologics
ADMA
$2.09B
$608K 2.03%
152,000
+88,000
+138% +$384K
KEM
19
DELISTED
KEMET Corporation
KEM
$582K 1.94%
+21,529
New +$523K
RIGL icon
20
Rigel Pharmaceuticals
RIGL
$868M
$483K 1.61%
22,550
-200
-0.9% -$4.12K
MLNX
21
DELISTED
Mellanox Technologies, Ltd.
MLNX
$444K 1.48%
3,789
-2,500
-40% -$284K
ACIA
22
DELISTED
Acacia Communications Inc
ACIA
$407K 1.36%
6,000
– –
S
23
DELISTED
Sprint Corporation
S
$399K 1.33%
76,500
+2,500
+3% +$14.7K
TGE
24
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$398K 1.33%
+18,000
New +$345K
STML
25
DELISTED
Stemline Therapeutics, Inc.
STML
$375K 1.25%
35,258
-4,742
-12% -$47.1K
1
2 3

Similar funds

SF
SBK Financial Richmond, Virginia $63.1M AUM 17.75% 1-Year Est. Return
CAM
Caprin Asset Management Henrico, Virginia $64.1M AUM 9.09% 1-Year Est. Return
SCFS
S.C. Financial Services Scottsdale, Arizona $65M AUM 9.66% 1-Year Est. Return
LCH
Lee Capital Holdings New York $65.4M AUM 20.44% 1-Year Est. Return
SGMPI
Spark Growth Management Partners II Boston, Massachusetts $66.6M AUM 51.19% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
AI
Abanco Investors Middletown, Rhode Island $57.9M AUM
DFAM
Deep Field Asset Management Beverly Hills, California $57.7M AUM 29.92% 1-Year Est. Return

Telemetry Investments's Q4 2019 Portfolio in Review

As of Q4 2019, Telemetry Investments held 63 positions worth $30M, down 13% from $34.7M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Telemetry Investments withdrew a net $6.12M in Q4 2019, closing 22 positions and reducing 13 holdings. Its most notable exit was Celgene Corp, an estimated $2.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 57% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Telemetry Investments opened a new position in iShares MSCI Emerging Markets ETF worth $1.12M.

  • Telemetry Investments's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 25,000 shares worth $1.12M.
  • Telemetry Investments added most to Affimed in Q4 2019, an estimated $389K increase.
  • Telemetry Investments's biggest Q4 2019 reduction was Kadmon Holdings, Inc., cutting an estimated $1.58M.
  • Telemetry Investments fully exited Celgene Corp in Q4 2019, selling an estimated $2.38M.
  • Telemetry Investments's ten largest holdings make up 58% of its $30M portfolio in Q4 2019.
  • Telemetry Investments opened 11 new positions and closed 22 in Q4 2019.
  • Telemetry Investments's portfolio value fell 13% quarter-over-quarter to $30M.

Based on Telemetry Investments's 13F filing for Q4 2019, filed 14 Feb 2020.